Skip to main content
. 2021 Nov 2;39(4):330–338. doi: 10.1111/ger.12590

TABLE 2.

Predetermined data items extracted from individual studies

Patient information and historyGender

Age

Primary Diagnosis and comorbid conditions

Medications and allergies

Type of bisphosphonate used and dosage

Duration of bisphosphonate therapy

History of current adverse event

Major symptoms described from the patient

Onset, location, duration of the symptoms

Previous history of mucosal adverse events (before treatment with bisphosphonate)

Clinical findings

Health screening assessment (blood pressure, body temperature)

Extraoral examination

Intraoral examination

Inspection and documentation of the mucosal adverse event (location, distribution and definition, size, shape, colour, consistency, texture)

Nikolsky's sign examination

Adjunctive visual tools (such as toluidine blue, fluorescence visualisation)

Coexistence on other mucosae

Differential Diagnosis

Diagnostic tests

Haematological and serological assays

Saliva analysis

Histopathological examination

Suggested management

Medical intervention/Drug holiday/Alteration of the medication

Time until resolution of symptoms/Healing period